MedPath

LB-P8

Generic Name
LB-P8
Drug Type
Biotech

Overview

LB-P8 is an investigational live biotherapeutic product consisting of a single bacterial strain (Leuconostoc citreum).

Background

LB-P8 is an investigational live biotherapeutic product consisting of a single bacterial strain (Leuconostoc citreum).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 2
Not yet recruiting
Posted: 2024/11/21
Sponsor:
LISCure Biosciences

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath